第一单位：
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
作者：
Vera,Adema [1]
;
Feiyang,Ma [2]
;
Rashmi,Kanagal-Shamanna [3]
;
Natthakan,Thongon [1]
;
Guillermo,Montalban-Bravo [1]
;
Hui,Yang [1]
;
Scott A,Peslak [4]
;
Feng,Wang [5]
;
Pamela,Acha [6]
;
Francesc,Sole [6]
;
Pamela,Lockyer [1]
;
Margherita,Cassari [7]
;
Jaroslaw P,Maciejewski [8]
;
Valeria,Visconte [8]
;
Irene,Gañán-Gómez [1]
;
Yuanbin,Song [9]
;
Carlos,Bueso-Ramos [3]
;
Matteo,Pellegrini [10]
;
Tuyet M,Tan [11]
;
Rafael,Bejar [11]
;
Jennifer S,Carew [12]
;
Stephanie,Halene [13]
;
Valeria,Santini [7]
;
Gheath,Al-Atrash [14]
;
Karen,Clise-Dwyer [14]
;
Guillermo,Garcia-Manero [1]
;
Gerd A,Blobel [15]
;
Simona,Colla [1]
作者单位：
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
[1]
Division of Rheumatology, Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, Michigan.
[2]
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
[3]
Division of Hematology/Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.;Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
[4]
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
[5]
MDS Research Group, Josep Carreras Leukaemia Research Institute, Universitat Autonoma de Barcelona, Badalona, Spain.
[6]
MDS Unit, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy.
[7]
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
[8]
Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
[9]
Department of Molecular, Cell and Developmental Biology, University of California, Los Angeles, California.
[10]
Moores Cancer Center, Univerity of California San Diego, San Diego, California.
[11]
University of Arizona Cancer Center, Tucson, Arizona.
[12]
Section of Hematology, Department of Internal Medicine and Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut.
[13]
Department of Stem Cell Transplantation and Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
[14]
Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
[15]
DOI
10.1158/2643-3230.BCD-21-0220
PMID
35926182
发布时间
2026-03-06
换一批
